SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050776
Filing Date
2018-08-09
Accepted
2018-08-09 08:02:47
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14075_110q.htm 10-Q 920939
2 EX-31.1 a18-14075_1ex31d1.htm EX-31.1 11799
3 EX-31.2 a18-14075_1ex31d2.htm EX-31.2 11810
4 EX-32.1 a18-14075_1ex32d1.htm EX-32.1 6490
  Complete submission text file 0001104659-18-050776.txt   3862342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20180630_def.xml EX-101.DEF 98926
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20180630_pre.xml EX-101.PRE 220521
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20180630_lab.xml EX-101.LAB 320557
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20180630_cal.xml EX-101.CAL 39540
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20180630.xsd EX-101.SCH 33804
10 XBRL INSTANCE DOCUMENT catb-20180630.xml EX-101.INS 753807
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 181003477
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences